← Eichor
Condition: Aga Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Aga

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia
Phase 3 · 1 location(s) · EMS · NCT04594018Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia
Phase 1/Phase 2 · 4 location(s) · Absci Pty Ltd. · NCT07317544Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site)
NA · 1 location(s) · Acorn Biolabs Inc. · NCT07107841Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Androgenic Alopecia
NA · 1 location(s) · Fujian Medical University Union Hospital · NCT07373054Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic Alopecia
NA · 1 location(s) · Kasr El Aini Hospital · NCT07502976Six-Month Single-Blind, Placebo-Controlled Study of a Dietary Supplement Supplement on Hair Growth in 45 Volunteers
NA · 2 location(s) · Industrial Farmacéutica Cantabria, S.A. · NCT06841458Thulium Laser and Growth Factors for Androgenetic Alopecia
NA · 1 location(s) · Universitätsklinikum Hamburg-Eppendorf · NCT07079657Exosome Therapy for Male Androgenetic Alopecia
Phase 2 · 1 location(s) · Zhang Han · NCT07693244Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia
EARLY_Phase 1 · 1 location(s) · Shanghai Zhongshan Hospital · NCT07012486Study of EPI-001 in Patients With Androgenetic Alopecia
Phase 1/Phase 2 · 1 location(s) · Epibiotech · NCT07618195Multi-Omics Insights Into Androgenetic Alopecia
Phase N/A · 1 location(s) · The First Affiliated Hospital of Xinxiang Medical College · NCT07603544A Clinical Study to Evaluate the Efficacy and Safety of Ultra in Promoting Hair Regrowth
NA · 2 location(s) · CynosureLutronic · NCT07588243Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia
Phase 3 · 13 location(s) · Industrial Farmacéutica Cantabria, S.A. · NCT05888922Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)
Phase 3 · 71 location(s) · Veradermics, Inc. · NCT071460221470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia
NA · 1 location(s) · Montefiore Medical Center · NCT05460611PRP Combined With Botulinum Toxin Type A Injection for the Treatment of Androgenetic Alopecia: A Study
Phase 2 · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT07335367Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia
Phase 2 · 1 location(s) · Shenzhen People's Hospital · NCT07370519Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia
Phase 3 · 1 location(s) · Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. · NCT07080931A Study to Evaluate Safety and Efficacy of OLX72021 in Healthy Males With Androgenetic Alopecia
Phase 1/Phase 2 · 1 location(s) · Olix Pharmaceuticals, Inc. · NCT07327359VENEZE Peptide Factor Hair Serum Compared With Topical 2% Minoxidil for Androgenetic Alopecia
NA · 2 location(s) · Institute of Dermatology, Thailand · NCT07536100Secretome vs. PRP Injections for Hair Density and Growth in Androgenetic Alopecia Patients
Phase 1/Phase 2 · 1 location(s) · PT. Prodia Stem Cell Indonesia · NCT07429253Androgenic Alopecia TH07 Clinical Trial
Phase 3 · 1 location(s) · Triple Hair Inc · NCT07435012JAK2 Expression in Androgenetic Alopecia Before and After Topical Minoxidil
NA · 1 location(s) · Kasr El Aini Hospital · NCT07563036A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alon
Phase 1/Phase 2 · 67 location(s) · BioNTech SE · NCT07070232Computer-Assisted Hair Restoration Study Using ARTAS System
NA · 2 location(s) · Venus Concept · NCT05938569A Study on the Treatment of Androgenetic Alopecia in Young Men With Umbilical Cord Mesenchymal Stem Cell Exosomes
Phase 1/Phase 2 · 1 location(s) · Shenzhen People's Hospital · NCT07203599
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.